ABCG2 and neoplasm: Tumor resistance is also acquired due to the overexpression of ATP-binding cassette (ABC) transporters.8 This can be overcome by designing chemotherapeutic drugs inhibiting ABC transporters, and thus overcoming multidrug resistance (MDR) and sensitizing the tumors for chemotherapeutic drugs.